Wnt signaling in liver cancer
- PMID: 18991612
- PMCID: PMC4446985
- DOI: 10.2174/138945008786786127
Wnt signaling in liver cancer
Abstract
Hepatocellular carcinoma (HCC) is a major cause of cancer death worldwide. As in many other types of cancer, aberrant activation of the canonical Wnt/beta-catenin signaling pathway is an important contributor to tumorigenesis. In HCC this frequently occurs through mutations in the N-terminal region of beta-catenin that stabilize the protein and permit an elevated level of constitutive transcriptional activation by beta-catenin/TCF complexes. In this article we review the abundant evidence that Wnt/beta-catenin signaling contributes to liver carcinogenesis. We also discuss what is known about the roles of Wnt signaling in liver development, regeneration, and stem cell behavior, in an effort to understand the mechanisms by which activation of the canonical Wnt pathway promotes tumor formation in this organ. The Wnt/beta-catenin pathway presents itself as an attractive target for developing novel rational therapies for HCC, a disease for which few successful treatment strategies are currently available.
Figures



Similar articles
-
Points of therapeutic intervention along the Wnt signaling pathway in hepatocellular carcinoma.Anticancer Agents Med Chem. 2011 Jul;11(6):549-59. doi: 10.2174/187152011796011019. Anticancer Agents Med Chem. 2011. PMID: 21554202 Review.
-
Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.Gastroenterology. 2006 Oct;131(4):1218-27. doi: 10.1053/j.gastro.2006.07.020. Epub 2006 Jul 24. Gastroenterology. 2006. PMID: 17030191
-
Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells.J Hepatol. 2008 May;48(5):780-91. doi: 10.1016/j.jhep.2007.12.020. Epub 2008 Feb 7. J Hepatol. 2008. PMID: 18313787 Free PMC article.
-
Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.J Hepatol. 2013 Nov;59(5):1107-17. doi: 10.1016/j.jhep.2013.07.001. Epub 2013 Jul 5. J Hepatol. 2013. PMID: 23835194 Review.
-
Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin.J Hepatol. 2011 Mar;54(3):506-12. doi: 10.1016/j.jhep.2010.07.020. Epub 2010 Oct 29. J Hepatol. 2011. PMID: 21093092 Free PMC article.
Cited by
-
Krüppel-like factor 8 is a new Wnt/beta-catenin signaling target gene and regulator in hepatocellular carcinoma.PLoS One. 2012;7(6):e39668. doi: 10.1371/journal.pone.0039668. Epub 2012 Jun 27. PLoS One. 2012. PMID: 22761862 Free PMC article.
-
An Overview of the Genomic Characterization of Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2021 Sep 7;8:1077-1088. doi: 10.2147/JHC.S270533. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34522690 Free PMC article. Review.
-
Aspirin-induced long-term tumor remission in hepatocellular carcinoma with adenomatous polyposis coli stop-gain mutation: A case report.World J Clin Cases. 2021 Aug 26;9(24):7189-7195. doi: 10.12998/wjcc.v9.i24.7189. World J Clin Cases. 2021. PMID: 34540977 Free PMC article.
-
Paracrine and autocrine regulation of gene expression by Wnt-inhibitor Dickkopf in wild-type and mutant hepatocytes.BMC Syst Biol. 2017 Oct 13;11(1):98. doi: 10.1186/s12918-017-0470-9. BMC Syst Biol. 2017. PMID: 29029622 Free PMC article.
-
5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β-catenin.Mol Oncol. 2016 Feb;10(2):195-212. doi: 10.1016/j.molonc.2015.09.008. Epub 2015 Sep 30. Mol Oncol. 2016. PMID: 26474915 Free PMC article.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. CA Cancer J Clin. 2005;55(2):74–108. - PubMed
-
- Bruix J, Boix L, Sala M, Llovet JM. Cancer Cell. 2004;5(3):215–219. - PubMed
-
- Branda M, Wands JR. Hepatology. 2006;43(5):891–902. - PubMed
-
- Llovet JM, Burroughs A, Bruix J. Lancet. 2003;362(9399):1907–1917. - PubMed
-
- Suriawinata AA, Thung SN. Clin Liver Dis. 2002;6(2):527–554. ix. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials